Olandag, Digna S.

HRN: 27-58-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2025
CEFTRIAXONE 1G (VIAL)
08/06/2025
08/12/2025
IV
600
Q6
DM FOOT WAGNER 4
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: